Acessibilidade / Reportar erro

Case for diagnosis. Keloidal cord-like lesion on the leg How to cite this article: Oliveira FS, Lopes NP, Talhari C, Schettini A. What is your diagnosis? An Bras Dermatol. 2020;95:383-6. ,☆☆ ☆☆ Study conducted at the Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta, Manaus, AM, Brazil.

Abstract

We report a 74-year-old male presented to an outpatient dermatology clinic in Manaus, Amazonas, with a one-year history of pruritic, keloidal lesions on his left lower extremity. Histopathology showed round structures in reticular dermis. Grocott methenamine silver stain revealed numerous round yeasts with thick double walls, occurring singly or in chains connected by tubular projections. The diagnosis was lobomycosis. Although the keloidal lesions presented by this patient are typical of lobomycosis, their linear distribution along the left lower limb is unusual.

KEYWORDS
Histology; Lacazia; Lobomycosis

Case report

In 2005, a 74-year-old male presented with a one-year history of pruritic, cutaneous lesions on his left lower extremity. Physical examination revealed an erythematous plaque and cord-like nodular lesions on the left thigh and leg. Culture, histopathological and mycological examinations were performed at that time but the patient was subsequently lost to follow-up until 2017, when he returned with complaints of recurrent, secondary bacterial infections on the left lower extremity. On physical exam, ulcers with perilesional induration, erythema, and desquamation were noted on the left leg (Fig. 1A). Additionally, cord-like, firm, brown, nodules were observed along the medial aspect of his left thigh and leg (Fig. 1B). Routine labs were unremarkable.

What is your diagnosis?

  1. Lymphangitic cutaneous leishmaniasis;

  2. Nontuberculous mycobacteriosis;

  3. Lobomycosis;

  4. Sporothricosis.

Figure 1
Ulcers with perilesional hardening of the skin, erythema and desquamation were seen on the left leg (A); cord-like, hard, brownish nodular lesions were also observed along the medial aspect of his left thigh and leg at physical examination (B).

Cutaneous biopsy was performed on the ulcer border (Fig. 2A). Histopathology showedy shows hyperkeratosis and epidermal acanthosis with a diffuse, predominantly lymphohistiocytic infiltrate. Giant cells, hemosiderin-laden histiocytes and increased vascularity are noted in the papillary dermis (Fig. 2B). Round structures are present in reticular dermis (Fig. 3A), and Grocott's methenamine silver stain reveals numerous round yeasts with thick double walls, occurring singly or in chains connected by tubular projections (Fig. 3B).

Figure 2
(A) Biopsy site (arrow). (B) Histopathology demonstrated hyperkeratosis and acanhosis, collagen fibroplasia vascular neoformation and diffuse inflammatory infiltrate consisting of lymphocytes, epithelioid cells, giant cells and hemosiderin-laden histiocytes were present in the papilar dermis (Hematoxylin & eosin, ×100).

Figure 3
(A) Round structures were seen in reticular dermis (Hematoxylin & eosin, ×200). (B) Grocott's methenamine silver stain revealed numerous round yeasts arranged containing thick double walls, occurring singly or in chains connected by tubular projections (Groccott, ×400).

Diagnosis: Lobomycosis.

Discussion

Lobomycosis, also known as Jorge Lobo's disease and lacaziosis, is a subcutaneous, chronic, granulomatous mycosis initially described by Jorge Lobo, in 1931. There are no systemic manifestations in lobomycosis.11 Lobo JO. Nova especie de blastomicose. Brasil Med. 1930;44:1227.,22 Paniz-Mondolfi A, Talhari C, Sander Hoffmann L, Connor DL, Talhari S, Bermudez-Villapol L, et al. Lobomycosis: an emerging disease in humans and delphinidae. Mycoses. 2012;55:298-309. Due to the similarity of its etiological agent, Lacazia loboi, to Paracoccidioides braziliensis, the mycosis had also been described as keloidal blastomycosis.33 Taborda PR, Taborda VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol. 1999;37:2031-3.Lacazia loboi has never been isolated in culture from humans or animals. Since the initial description of lobomycosis in patients from the Brazilian Amazon Region, other cases have been reported in tropical and subtropical regions of Latin American countries.22 Paniz-Mondolfi A, Talhari C, Sander Hoffmann L, Connor DL, Talhari S, Bermudez-Villapol L, et al. Lobomycosis: an emerging disease in humans and delphinidae. Mycoses. 2012;55:298-309.,44 Elsayed S, Kuhn SM, Barber D, Church DL, Adams S, Kasper R. Human case of lobomycosis. Emerg Infect Dis. 2004;10:715-8. The few lobomycosis reports from outside these regions have occurred predominantly in patients who had traveled through endemic areas. In 2008, cases were diagnosed in South Africa in patients with no history of travelling to known endemic areas.55 Al-Daraji WI, Husain E, Robson A. Lobomycosis in African patients. Br J Dermatol. 2008;159:234-6.

An important fact related to this mycosis was the discovery, in the Florida coast in 1970, of a dolphin with a clinical and histopathological disease similar to human lobomycosis.22 Paniz-Mondolfi A, Talhari C, Sander Hoffmann L, Connor DL, Talhari S, Bermudez-Villapol L, et al. Lobomycosis: an emerging disease in humans and delphinidae. Mycoses. 2012;55:298-309.,66 Migaki G, Valerio MG, Irvine B, Garner FM. Lobo's disease in an Atlantic bottle-nosed dolphin. J Am Vet Med Assoc. 1971;159:578-82. Subsequently, other dolphins with the same disease were found in the Atlantic coast of the United States, coastal region of Latin American and Caribbean countries, coastal region of the Southern Brazilian states of Rio Grande do Sul and Santa Catarina, Pacific coast and Indian Ocean.77 Bossart GD, Fair P, Schaefer AM, Reif JS. Health and environmental risk assessment project for bottlenose dolphins Tursiops truncatus from the southeastern USA I. Infectious diseases. Dis Aquat Org. 2017;125:141-53. There is only one documented case of dolphin to human transmission of lobomycosis: an aquarium attendant who worked in an aquarium pool with an infected bottlenose dolphin (Tursiops truncatus) caught in Bay of Biscay, Spain.88 Symmers WS. A possible case of Lobo's disease acquired in Europe from a bottle-nosed dolphin (Tursiops truncatus). Bull Soc Pathol Exot Filiales. 1983;76(Pt 2):777-84.

The disease is clinically characterized by the presence of nodular, verrucous or keloidal lesions, which are found alone or in plaques, localized or disseminated, with a generally long evolution. The most common clinical presentation is keloidal, characterized by firm, shiny, pinkish-brown to brown nodules.22 Paniz-Mondolfi A, Talhari C, Sander Hoffmann L, Connor DL, Talhari S, Bermudez-Villapol L, et al. Lobomycosis: an emerging disease in humans and delphinidae. Mycoses. 2012;55:298-309. Ulceration may occur in areas subject to trauma. Development of squamous cell carcinoma in long-standing lesions may occur.99 Nogueira L, Rodrigues L, Rodrigues CAC, Santos M, Talhari S, Talhari C. Lobomycosis and squamous cell carcinoma. An Bras Dermatol. 2013;88:293-5.

Another clinical aspect that drew attention in this patient was the linear arrangement of lesions along the leg and thigh. It is admitted that the spread of the disease occurs by contiguity, and through lymphatic route; however, an aspect similar to that observed in the present case is not common.

  • Financial support
    None declared.
  • How to cite this article: Oliveira FS, Lopes NP, Talhari C, Schettini A. What is your diagnosis? An Bras Dermatol. 2020;95:383-6.
  • ☆☆
    Study conducted at the Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta, Manaus, AM, Brazil.

References

  • 1
    Lobo JO. Nova especie de blastomicose. Brasil Med. 1930;44:1227.
  • 2
    Paniz-Mondolfi A, Talhari C, Sander Hoffmann L, Connor DL, Talhari S, Bermudez-Villapol L, et al. Lobomycosis: an emerging disease in humans and delphinidae. Mycoses. 2012;55:298-309.
  • 3
    Taborda PR, Taborda VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol. 1999;37:2031-3.
  • 4
    Elsayed S, Kuhn SM, Barber D, Church DL, Adams S, Kasper R. Human case of lobomycosis. Emerg Infect Dis. 2004;10:715-8.
  • 5
    Al-Daraji WI, Husain E, Robson A. Lobomycosis in African patients. Br J Dermatol. 2008;159:234-6.
  • 6
    Migaki G, Valerio MG, Irvine B, Garner FM. Lobo's disease in an Atlantic bottle-nosed dolphin. J Am Vet Med Assoc. 1971;159:578-82.
  • 7
    Bossart GD, Fair P, Schaefer AM, Reif JS. Health and environmental risk assessment project for bottlenose dolphins Tursiops truncatus from the southeastern USA I. Infectious diseases. Dis Aquat Org. 2017;125:141-53.
  • 8
    Symmers WS. A possible case of Lobo's disease acquired in Europe from a bottle-nosed dolphin (Tursiops truncatus). Bull Soc Pathol Exot Filiales. 1983;76(Pt 2):777-84.
  • 9
    Nogueira L, Rodrigues L, Rodrigues CAC, Santos M, Talhari S, Talhari C. Lobomycosis and squamous cell carcinoma. An Bras Dermatol. 2013;88:293-5.

Publication Dates

  • Publication in this collection
    24 July 2020
  • Date of issue
    May-Jun 2020

History

  • Received
    1 Apr 2018
  • Accepted
    4 July 2019
  • Published
    19 Mar 2020
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br